Brain immune interactions and air pollution: macrophage inhibitory factor (MIF), prion cellular protein (PrPC), Interleukin-6 (IL-6), interleukin 1 receptor antagonist (IL-1Ra), and interleukin-2 (IL-2) in cerebrospinal fluid and MIF in serum differentiate urban children exposed to severe vs. low air pollution

Frontiers in Neuroscience

Volumn , Issue 7 OCT, 2013, Pages

  Calderón Garcidueñas, Lilian ^a,b   Cross, Janet V ^c   Franco Lira, Maricela ^b   Aragón Flores, Mariana ^b   Kavanaugh, Michael ^a   Torres Jardón, Ricardo ^d   Chao, Chih kai ^a   Thompson, Charles ^a   Chang, Jing ^e   Zhu, Hongtu ^e   D'Angiulli, Amedeo ^f  

^a UNIVERSITY OF MONTANA   (United States)

^b Secretaria de la Defensa Nacional   (Mexico)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e University of North Carolina at Chapel Hill   (United States)

^f CARLETON UNIVERSITY   (Canada)

Author keywords

Air pollution; Alzheimer; Children; Innate immunity; Neurodegeneration; Neuroinflammation; Particulate matter; Prion cellular protein

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; PRION PROTEIN; RANTES;

AIR POLLUTION; ARTICLE; BRAIN GROWTH; CENTRAL NERVOUS SYSTEM; CHILD; COGNITIVE DEFECT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMMUNOLOGY; SCHOOL CHILD; URBAN AREA;

EID: 84888814562     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2013.00183     Document Type: Article

References (143)

1. Aguzzi, A., and Haass, C. (2003). Games played by rogue proteins in prion disorders and Alzheimer's disease. Science. 302, 814-818. doi:10.1126/science.1087348
2. Akash, M. S., Rehman, K., and Chen, S. (2013). IL-1Ra and its delivery strategies: inserting the association in perspective. Pharm. Res. doi:10.1007/s11095-013-1118-0. [Epub ahead of print].
3. Alfaidy, N., Chauvet, S., Donadio-Andrei, S., Salomon, A., Saoudi, Y., Richaud, P., et al. (2013). Prion protein expression and functional importance in developmental angiogenesis: role in oxidative stress and copper homeostasis. Antioxid. Redox Signal. 18, 400-411. doi:10.1089/ars.2012.4637
4. Altmeppen, H. C., Puig, B., Dohler, F., Thurm, D. K., Falker, C., Krasemann, S., et al. (2012). Proteolytic processing of the prion protein in health and disease. Am. J. Neurodegener. Dis. 1, 15-31.
5. Anisman, H., and Hayley, S. (2012). Inflammatory factors contribute to depression and its comorbid conditions. Sci. Signal. 5:pe45. doi:10.1126/scisignal.2003579
6. Arend, W. P. (2002). The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 13, 323-340. doi:10.1016/S1359-6101(02)00020-5
7. Aung, H. H., Lame, M. W., Gohil, K., He, G., Denison, M. S., Rutledge, J. C., et al. (2011). Comparative gene responses to collected ambient particles in vitro: endothelial responses. Physiol. Genomics. 43, 917-929. doi:10.1152/physiolgenomics.00051.2011
8. Bacher, M., Deuster, O., Aljabari, B., Egensperger, R., Neff, F., Jessen, F., et al. (2010). The role of macrophage migration inhibitory factor in Alzheimer's disease. Mol. Med. 16, 116-121. doi:10.2119/molmed.2009.00123
9. Baine, I., Basu, S., Ames, R., Sellers, R. S., and Macian, F. (2013). Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells. J. Immunol. 190, 1008-1016. doi:10.4049/jimmunol.1200792
10. Barrientos, R. M., Hein, A. M., Frank, M. G., Watkins, L. R., and Maier, S. F. (2012). Intracisternal interleukin-1 receptor antagonist prevents postoperative cognitive decline and neuroinflammatory response in aged rats. J. Neurosci. 32, 14641-14648. doi:10.1523/JNEUROSCI.2173-12.2012
11. Barry, A. E., Klyubin, I., McDonald, J. M., Mably, A. J., Farrell, M. A., Scott, M., et al. (2011). Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J. Neurosci. 31, 7259-7263. doi:10.1523/JNEUROSCI.6500-10.2011
12. Baune, B. T., Konrad, C., Grotegerd, D., Suslow, T., Birosova, E., Ohrmann, P., et al. (2012). Interleukin-6 gene (IL6): a possible role of brain morphology in the healthy adult brain. J. Neuroinflammation 9:125. doi:10.1186/1742-2094-9-125
13. Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., et al. (1993). MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia. Nature. 365, 756-759. doi:10.1038/365756a0
14. C knockout mice. Biochim. Biophys. Res. Commun. 418, 27-32. doi:10.1016/j.bbrc.2011.12.098
15. Bilbo, S. D., and Schwarz, J. M. (2012). The immune system and developmental programming of brain and behavior. Front. Neuroendocrinol. 33, 267-286. doi:10.1016/j.yfrne.2012.08.006
16. Bleier, B. S., Feldman, R., Sadow, P. M., Wu, A., Ting, J., and Metson, R. (2012). The accessory posterolateral nerve: an immunohistological analysis. Am. J. Rhinol. Allergy. 26, 271-273. doi:10.2500/ajra.2012.26.3804
17. Block, M., and Calderón-Garcidueñas, L. (2009). Air Pollution: mechanisms of neuroinflammation and CNS disease. Trends Neurosci. 32, 506-516. doi:10.1016/j.tins.2009.05.009
18. Bloom, D. E. (2011). 7 Billion and counting. Science. 333, 562-569. doi:10.1126/science.1209290
19. Bradford, B. M., and Mabbott, N. A. (2012). Prion disease and the innate immune system. Viruses. 4, 3389-3419. doi:10.3390/v4123389
20. Breitling, L. P., Muller, H., Stegmaier, C., Kliegel, M., and Brenner, H. (2012). Association of prion protein with cognitive functioning in humans. Exp. Gerontol. 47, 919-24. doi:10.1016/j.exger.2012.08.001
21. Bremer, J., Baumann, F., Tiberi, C., Wessig, C., Fischer, H., Schwarz, P., et al. (2010). Axonal prion protein is required for peripheral myelin maintenance. Nat. Neurosci. 13, 310-318. doi:10.1038/nn.2483
22. Brown, D. R., Schmidt, B., and Kretzschmar, H. A. (1997). Effects of oxidative stress on prion protein expression in PC12 cells. Int. J. Dev. Neurosci. 15, 961-972. doi:10.1016/S0736-5748(97)00042-7
23. Bucala, R. (2013). MIF, MIF alleles, and prospects for therapeutic intervention in autoimmunity. J. Clin. Immunol. 33(Suppl. 1), S72-S78. doi:10.1007/s10875-012-9781-1
24. Calderón-Garcidueñas, L., Engle, R., Mora-Tiscareño, A., Styner, M., Gomez-Garza, G., Zhu, H., et al. (2011a). Exposure to severe urban pollution influences cognitive outcomes, brain volume and systemic inflammation in clinically healthy children. Brain Cognition 77, 345-355. doi:10.1016/j.bandc.2011.09.006
25. Calderón-Garcidueñas, L., D'Angiulli, A., Kulesza, R. J., Torres-Jardón, R., Romero, L., Keefe, S., et al. (2011b). Air pollution is associated with brainstem auditory nuclei pathology and delayed brainstem auditory evoked potentials. Int. J. Dev. Neurosci. 29, 365-375. doi:10.1016/j.ijdevneu.2011.03.007
26. Calderón-Garcidueñas, L., Franco-Lira, M., Henríquez-Roldán, C., González-Maciel, A., Reynoso-Robles, R., Villarreal-Calderon, R., et al. (2010). Urban air pollution: influences on olfactory function and pathology in exposed children and young adults. Exp. Toxicol. Pathol. 62, 91-102. doi:10.1016/j.etp.2009.02.117
27. Calderón-Garcidueñas, L., Franco-Lira, M., Mora-Tiscareño, A., Medina-Cortina, H., Torres-Jardón, R., and Kavanaugh, M. (2013). Early Alzheimer's and Parkinson's disease pathology in urban children: friend versus foe responses-it is time to face the evidence. Biomed. Res. Int. doi:10.1155/2013/161687
28. Calderón-Garcidueñas, L., Franco-Lira, M., Torres-Jardón, R., Henriquez-Roldán, C., Valencia-Salazar, G., González-Maciel, A., et al. (2007). Pediatric and systemic effects of chronic air pollution exposure: nose, lung, heart, and brain pathology. Toxicol. Pathol. 35, 154-162. doi:10.1080/01926230601059985
29. Calderón-Garcidueñas, L., Kavanaugh, M., Block, M. L., D'Angiulli, A., Delgado-Chávez, R., Torres-Jardón, R., et al. (2012a). Neuroinflammation, hyperphosphorilated tau, diffuse amyloid plaques and down-regulation of the cellular prion protein in air pollution exposed children and adults. J. Alzheimers Dis. 28, 93-107.
30. Calderón-Garcidueñas, L., Mora-Tiscareño, A., Styner, M., Gómez-Garza, G., Zhu, H., Torres-Jardón, R., et al. (2012b). White matter hyperintensities, systemic inflammation, brain growth and cognitive functions in children exposed to air pollution. J. Alzheimers Dis. 31, 183-91.
31. Calderón-Garcidueñas, L., Macías-Parra, M., Hoffmann, H. J., Valencia-Salazar, G., Henríquez-Roldán, C., Monte, O. C., et al. (2009). Immunotoxicity and environment: immunodysregulation and systemic inflammation in children. Toxicol. Pathol. 37, 161-169. doi:10.1177/0192623308329340
32. Calderón-Garcidueñas, L., Maronpot, R. R., Torres-Jardón, R., Henriquez-Roldán, C., Schoonhoven, R., Acuña-Ayala, H., et al. (2003). DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration. Toxicol. Pathol. 31, 524-538. doi:10.1080/01926230390226645
33. Calderón-Garcidueñas, L., Solt, A. C., Henríquez-Roldán, C., Torres-Jardón, R., Nuse, B., Herritt, L., et al. (2008a). Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain-barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol. Pathol. 36, 289-310.
34. Calderón-Garcidueñas, L., Mora-Tiscareño, A., Gómez-Garza, G., Broadway, J., Chapman, S., Valencia-Salazar, G., et al. (2008b). Air pollution, cognitive deficits and brain abnormalities: a pilot study with children and dogs. Brain Cogn. 68, 117-127. doi:10.1016/j.bandc.2008.04.008
35. Calderón-Garcidueñas, L., and Torres-Jardón, R. (2012). Air pollution, socioeconomic status and children's cognition in megacities: the Mexico City scenario. Front. Psychol. 3:217. doi:10.3389/fpsyg.2012.00217
36. C in human cerebrospinal fluid after spinal cord injury. Prion. 4, 80-86. doi:10.4161/pri.4.2.11756
37. Castellani, R. J., and Perry, G. (2012). Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress. Arch. Med. Res. 43, 694-698. doi:10.1016/j.arcmed.2012.09.009
38. Cattaneo, A., Gennarelli, M., Uher, R., Breen, G., Farmer, A., Aitchison, K. J., et al. (2013). Candidate genes expression profile aasociated with antidepressants response in the GENDEP study: differentiating between baseline predictors and longitudinal targets. Neuropsychopharmacology. 38, 377-385. doi:10.1038/npp.2012.191
39. Cawthorne, C., Prenant, C., Smigova, A., Julvan, P., Maroy, R., Herholz, K., et al. (2011). Biodistribution, pharmacokinetics and metabolism of interleukin-1 receptor antagonist (IL-1RA) using [18F] IL1RA and PET imaging in rats. Br. J. Pharmacol. 162, 659-672. doi:10.1111/j.1476-5381.2010.01068.x
40. Checler, F., and Vincent, B. (2002). Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci. 25, 616-620. doi:10.1016/S0166-2236(02)02263-4
41. Chen, B., and Kan, H. (2008). Air pollution and population health: a global challenge. Environ. Health Prev. Med. 13, 94-101. doi:10.1007/s12199-007-0018-5
42. Chen, R. J., Chang, W. W., Lin, Y. C., Cheng, P. L., and Chen, Y. R. (2013). Alzheimer's amyloid-β oligomers rescue cellular prion protein induced Tau reduction via Fyn pathways. ACS Chem. Neurosci. 4, 1287-1296. doi:10.1021/cn400085q
43. Chikly, B., and Quaghebeur, J. (2013). Reassessing cerebrospinal fluid (CSF) hydrodynamics: a literature review presenting a novel hypothesis for CSF physiology. J. Bodyw. Mov. Ther. 17, 344-354. doi:10.1016/j.jbmt.2013.02.002
44. Choi, C. J., Anantharam, V., Saetveit, N. J., Houk, R. S., Kanthasamy, A., and Kanthasamy, A. G. (2007). Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death. Toxicol. Sci. 98, 495-509. doi:10.1093/toxsci/kfm099
45. Cieri, N., Camisa, B., Cocchiarella, F., Forcato, M., Oliveira, G., Provasi, E., et al. (2013). IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. Blood. 121, 573-584. doi:10.1182/blood-2012-05-431718
46. Combarros, O., Van Duijn, C. M., Hammond, N., Belbin, O., Arias-Vásquez, A., Cortina-Borja, M., et al. (2009). Replication by the epistasis project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease. J. Neuroinflammation 6:22. doi:10.1186/1742-2094-6-22
47. Cox, G. M., Kithcart, A. P., Pitt, D., Guan, Z., Alexander, J., Williams, J. L., et al. (2013). Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation. J. Immunol. 191, 1043-1054. doi:10.4049/jimmunol.1200485
48. Craig-Schapiro, R., Kuhn, M., Xiong, C., Pickering, E. H., Liu, J., Misko, T. P., et al. (2011). Multiplex immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis. PLoS ONE 6:e18850. doi:10.1371/journal.pone.0018850
49. De La Torre, J. C. (2012). A turning point for Alzheimer's disease? Biofactors 38, 78-83. doi:10.1002/biof.200
50. Del Campo, M., Mollenhauer, B., Bertolotto, A., Engelborghs, S., Hampel, H., Simonsen, A. H., et al. (2012). Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update. Biomark. Med. 6, 419-430. doi:10.2217/bmm.12.46
51. Del Rey, A., Balschun, D., Wetzel, W., Randolf, A., and Besedovsky, H. O. (2013). A cytokine network involving brain-borne IL-1β, IL-1Ra, IL-18, IL-6 and TNF-α operates during long-term potentiation and learning. Brain Behav. Immun. 33, 15-23. doi:10.1016/j.bbi.2013.05.011
52. Dhuria, S. V., Hanson, L. R., and Frey, W. H. III. (2010). Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J. Pharm. Sci. 99, 1654-1673. doi:10.1002/jps.21924
53. Ding, T., Zhou, X., Kouadir, M., Shi, F., Yang, Y., Liu, J., et al. (2013). Cellular prion protein participates in the regulation of inflammatory response and apoptosis in BV2 microglia during infection with Mycobacterium bovis. J. Mol. Neurosci. 51, 118-126. doi:10.1007/s12031-013-9962-2
54. Drake, C., Boutin, H., Jones, M. S., Denes, A., McColl, B. W., Selvarajah, J. R., et al. (2011). Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav. Immun. 25, 1113-1122. doi:10.1016/j.bbi.2011.02.008
55. Dziedzic, T. (2006). Systemic inflammatory markers and risk of dementia. Am. J. Alzheimers Dis. Other Demen. 21, 258-262. doi:10.1177/1533317506289260
56. Edwards, K. M., Bosch, J. A., Engeland, C. G., Cacioppo, J. T., and Marucha, P. T. (2010). Elevated macrophage migration inhibitory factor (MIF) is associated with depressive symptoms, blunted cortisol reactivity to acute stress, and lowered morning cortisol. Brain Behav. Immun. 24, 1202-1208. doi:10.1016/j.bbi.2010.03.011
57. Ferrer, I., Blanco, R., Carmona, M., Puig, B., Ribera, R., Rey, M. J., et al. (2001). Prion protein expression in senile plaques in Alzheimer's disease. Acta Neuropathol. 101, 49-56.
58. Freiria-Oliveira, A. H., Blanch, G. T., Li, H., Colombari, E., Colombari, D. S., and Sumners, C. (2013). Macrophage inhibitory factor in the nucleus of solitary tract decreases blood pressure in SHRs. Cardiovasc. Res. 97, 153-160. doi:10.1093/cvr/cvs297
59. Frodl, T., Carballedo, A., Hughes, M. M., Saleh, K., Fagan, A., Skokauskas, N., et al. (2012). Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL6 levels are associated with reduced hippocampal volumes in major depressive disorder. Transl. Psychiatry 2:e88. doi:10.1038/tp.2012.14
60. Gadek-Michalska, A., and Bugajski, J. (2010). Interleukin-1 (IL-1) in stress-induced activation of limbic-hypothalamic-pituitary adrenal axis. Pharmacol. Rep. 62, 969-982.
61. Galimberti, D., Venturelli, E., Fenoglio, C., Guidi, I., Villa, C., Bergamaschini, L., et al. (2008). Intratechal levels of IL6, IL11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration. J. Neurol. 255, 539-544. doi:10.1007/s00415-008-0737-6
62. Gaspar, K., Kukova, G., Bunemann, E., Buhren, B. A., Sonkolv, E., Szollosi, A. G., et al. (2013). The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation. J. Dermatol. Sci. 71, 12-21. doi:10.1016/j.jdermsci.2013.04.011
63. Gertz, K., Kronenberg, G., Kälin, R. E., Baldinger, T., Werner, C., Balkaya, M., et al. (2012). Essential role of interleukin-6 in post-stroke angiogenesis. Brain. 135, 1964-1980. doi:10.1093/brain/aws075
64. Gimbel, D. A., Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., et al. (2010). Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J. Neurosci. 30, 6367-6374. doi:10.1523/JNEUROSCI.0395-10.2010
65. Giralt, M., Ramos, R., Quintana, A., Ferrer, B., Erta, M., Castro-Freire, M., et al. (2013). Induction of atypical EAE mediated by transgenic production of IL6 in astrocytes in the absence of systemic IL6. Glia. 61, 587-600. doi:10.1002/glia.22457
66. Girard, S., Sébire, H., Brochu, M. E., Briota, S., Sarret, P., and Sébire, G. (2012). Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries. Brain Behav. Immun. 26, 1331-1339. doi:10.1016/j.bbi.2012.09.001
67. Gourdain, P., Ballerini, C., Nicot, A. B., and Carnaud, C. (2012). Exacerbation of experimental autoimmune encephalomyelitis in prion protein PrPc-null mice: evidence for a critical role of the central nervous system. J. Neuroinflammation 9:25. doi:10.1186/1742-2094-9-25
68. Grassi-Oliveira, R., Bauer, M. E., Pezzi, J. C., Teixeira, A. L., and Brietzke, E. (2011). Interleukin-6 and verbal memory in recurrent major depressive disorder. Neuro Endocrinol. Lett. 32, 540-544.
69. Griffiths, H. H., Whitehouse, I. J., and Hooper, N. M. (2012). Regulation of amyloid-β production by the prion protein. Prion. 6, 217-222. doi:10.4161/pri.18988
70. Griffiths, M., Neal, J. W., and Gasque, P. (2007). Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins. Int. Rev. Neurobiol. 82, 29-55. doi:10.1016/S0074-7742(07)82002-2
71. Gunther, E. C., and Striitmatter, S. M. (2010). Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease. J. Mol. Med. 88, 331-338. doi:10.1007/s00109-009-0568-7
72. Hagman, S., Raunio, M., Rossi, M., Dastidar, P., and Elovaara, I. (2011). Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: prospective clinical and MRI follow-up Study. J. Neuroimmunol. 234, 141-147. doi:10.1016/j.jneuroim.2011.02.009
73. Helmy, A. A., Naseer, M. M., Shafie, S. E., and Nada, M. A. (2012). Role of interleukin 6 and alpha-globulins in differentiating Alzheimer and vascular dementias. Neurodegener. Dis. 9, 81-86. doi:10.1159/000329568
74. Hu, W., Rosenberg, R. N., and Stüve, O. (2007). Prion proteins: a biological role beyond prion diseases. Acta Neurol. Scand. 116, 75-82. doi:10.1111/j.1600-0404.2007.00868.x
75. Jellinger, A. K. (2010). Intrathecal levels of IL6 in Alzheimer's disease. J. Neurol. 257, 142. doi:10.1007/s00415-009-5312-2
76. Jiménez-Huete, A., Lievens, P. M., Vidal, R., Piccardo, P., Ghetti, B., Tagliavini, F., et al. (1998). Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am. J. Pathol. 153, 1561-1572. doi:10.1016/S0002-9440(10)65744-6
77. Ju, S. T., Sharma, R., Gaskin, F., and Fu, S. M. (2012). IL-2 controls trafficking receptor gene expression and Th2 response for skin and lung inflammation. Clin. Immunol. 145, 82-88. doi:10.1016/j.clim.2012.07.015
78. Kaiser, D. M., Acharya, M., Leighton, P. L. A., Wang, H., Daude, N., Wohlgemuth, S., et al. (2012). Amyloid beta precursor protein and prion protein have a conserved interaction affecting cell adhesion and CNS development. PLoS ONE 7:e51305. doi:10.1371/journal.pone.0051305
79. Kamat, A., Lyons, J. L., Misra, V., Uno, H., Morgello, S., Singer, E. J., et al. (2012). Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. J. Acquir. Immune Defic. Syndr. 60, 234-243. doi:10.1097/QAI.0b013e318256f3bc
80. Kessels, H. W., Nguyen, L. N., Nabavi, S., and Malinow, R. (2010). The prion protein as a receptor for amyloid-beta. Nature 466, E3-E4. doi:10.1038/nature09217
81. Kudo, W., Petersen, R. B., and Lee, H. G. (2013). Cellular prion protein and Alzheimer disease: link to oligomeric amyloid-β and neuronal cell death. Prion. 7, 114-116. doi:10.4161/pri.22848
82. Kullmann, J. S., Grigoleit, J. S., Wolf, O. T., Engler, H., Oberbeck, R., Elsenbruch, S., et al. (2013). Experimental human endotoxemia enhances brain activity during social cognition. Soc. Cogn. Affect. Neurosci. doi:10.1093/scan/nst049. [Epub ahead of print].
83. Kuwahara, C., Takeuchi, A. M., Nishimura, T., Haraguchi, K., Kubosaki, A., Matsumoto, Y., et al. (1999). Prions prevent neuronal cell-line death. Nature. 400, 225-226. doi:10.1038/22241.
84. Larson, M., Sherman, M. A., Amar, F., Nuvolone, M., Schneider, J. A., Bennett, D. A., et al. (2012). The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease. J. Neurosci. 32, 16857-16871. doi:10.1523/JNEUROSCI.1858-12.2012
85. Laurén, J., Gimbel, D. A., Nygaared, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009). Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature. 457, 1128-1132. doi:10.1038/nature07761
86. Lee, K. S., Chung, J. H., Lee, K. H., Shin, M. J., Oh, B. H., and Hong, C. H. (2008). Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment. Immunol. Lett. 121, 105-109. doi:10.1016/j.imlet.2008.09.004
87. Levesque, S., Surace, M. J., McDonald, J., and Block, M. L. (2011). Air pollution and the brain: subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease. J. Neuroinflammation 8:105. doi:10.1186/1742-2094-8-105
88. Levesque, S., Taetzsch, T., Lull, M. E., Johnson, J. A., McGraw, C., and Block, M. L. (2013). The role of MAC1 in diesel exhaust particle-induced microglial activation and loss of dopaminergic neuron function. J. Neurochem. 125, 756-765. doi:10.1111/jnc.12231
89. Ley, E. J., Clond, M. A., Singer, M. B., and Salim, A. (2011). IL6 deficiency affects function after traumatic brain injury. J. Surg. Res. 170, 253-256. doi:10.1016/j.jss.2011.03.006
90. Lucchini, R. G., Dorman, D. C., Elder, A., and Veronesi, B. (2012). Neurological impacts from inhalation of pollutants and the nose-brain connection. Neurotoxicology. 33, 838-841. doi:10.1016/j.neuro.2011.12.001
91. Malekzadeh, A., De Groot, V., Beckerman, H., Van Oosten, B. W., Blankenstein, M. A., and Teunissen, C. (2012). Challenges in multiplex and monoplex platforms for the discovery of inflammatory profiles in neurodegenerative diseases. Methods. 56, 508-513. doi:10.1016/j.ymeth.2012.03.017
92. Martinez, A. N., Mehra, S., and Kaushal, D. (2013). Role of Interleukin-6 (IL6) in innate immunity to Mycobacterium tuberculosis infection. J. Infect. Dis. 207, 1253-1261. doi:10.1093/infdis/jit037
93. Martins, V. R., Beraldo, F. H., Hajj, G. N., Lopes, M. H., Lee, K. S., Prado, M. A., et al. (2010). Prion protein: orchestrating neurotrophic activities. Curr. Issues Mol. Biol. 12, 63-86.
94. Massimino, M. L., Redaelli, M., Bertoli, A., Sorgato, M. C., and Mucignat-Caretta, C. (2013). Altered behavioral aspects of aged mice lacking the cellular prion protein. Physiol. Behav. 119C, 86-91. doi:10.1016/j.physbeh.2013.06.006
95. Milhavet, O., and Lehmann, S. (2002). Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res. Brain Res. Rev. 38, 328-339. doi:10.1016/S0165-0173(01)00150-3
96. Mitsios, N., Saka, M., Krupinski, J., Pennucci, R., Sanfeliu, C., Turu, M. M., et al. (2007). Cellular prion protein is increased in the plasma and peri-infarcted brain tissue after acute stroke. J. Neurosci. Res. 85, 602-611. doi:10.1002/jnr.21142
97. Molina, L. T., and Molina, M. J. (2004). Improving air quality in megacities: Mexico City case study. Ann. N.Y. Acad. Sci. 1023, 142-158. doi:10.1196/annals.1319.006
98. Mooijaart, S. P., Sattar, N., Trompet, S., Lucke, J., Stott, D. J., Ford, I., et al. (2013). Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. J. Intern. Med. 274, 77-85. doi:10.1111/joim.12052
99. Moon, H. Y., Kim, S. H., Yang, Y. R., Song, P., Yu, H. S., Park, H. G., et al. (2012). Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise. Proc. Natl. Acad. Sci. U.S.A. 109, 13094-13099. doi:10.1073/pnas.1205535109
100. Nunomura, A., Castellani, R. J., Lee, H. G., Moreira, P. I., Zhu, X., Perry, G., et al. (2006). Neuropathology in Alzheimer's disease: awakening from a hundred-year old dream. Sci. Aging Knowledge Environ. 2006, pe10. doi:10.1126/sageke.2006.8.pe10
101. Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., et al. (2001). Oxidative damage is the earliest event in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 60, 759-767.
102. Nunomura, A., Tamaoki, T., Motohashi, N., Nakamura, M., McKeel, D. W. Jr., Tabaton, M., et al. (2012a). The earliest stage of cognitive impairment in transition from normal aging to Alzheimer's disease is marked by prominent RNA oxidation in vulnerable neurons. J. Neuropathol. Exp. Neurol. 71, 233-241. doi:10.1097/NEN.0b013e318248e614
103. Nunomura, A., Moreira, P. I., Castellani, R. J., Lee, H. G., Zhu, X., Smith, M. A., et al. (2012b). Oxidative damage to RNA in aging and neurodegenerative disorders. Neurotox. Res. 22, 231-248. doi:10.1007/s12640-012-9331-x
104. Nygaard, H. B., and Strittmatter, S. M. (2009). Cellular protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease. Arch. Neurol. 66, 1325-1328. doi:10.1001/archneurol.2009.223
105. Oh, J. M., Choi, E. K., Carp, R. I., and Kim, Y. S. (2012). Oxidative stress impairs autophagic flux in prion protein-deficient hippocampal cells. Autophagy. 8, 1448-1461. doi:10.4161/auto.21164
106. Ohta, S., Misawa, A., Fukaya, R., Inoue, S., Kanemura, Y., Okano, H., et al. (2012). Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells. J. Cell Sci. 125, 3210-3220. doi:10.1242/jcs.102210
107. Papassotiropoulos, A., Hock, C., and Nitsch, R. M. (2001). Genetics of Interleukin 6: implications for Alzheimer's disease. Neurobiol. Aging. 22, 863-871. doi:10.1016/S0197-4580(01)00294-9
108. Peters, V. A., Joesting, J. J., and Freund, G. G. (2013). IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Brain Behav. Immun. 32, 1-8. doi:10.1016/j.bbi.2012.11.006
109. Popko, B. (2010). Myelin maintenance: axonal support required. Nat. Neurosci. 13, 275-277. doi:10.1038/nn0310-275
110. Popp, J., Bacher, M., Kölsch, H., Noelker, C., Deuster, O., Dodel, R., et al. (2009). Macrophage inhibitory factor in mild cognitive impairment and Alzheimer's disease. J. Psychiatr. Res. 43, 749-753. doi:10.1016/j.jpsychires.2008.10.006
111. Pradillo, J. M., Denes, A., Greenhalgh, A. D., Boutin, H., Drake, C., McColl, B. W., et al. (2012). Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats. J. Cereb. Blood Flow Metab. 32, 1810-1819. doi:10.1038/jcbfm.2012.101
112. Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J. S., et al. (2007). Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 55, 453-462. doi:10.1002/glia.20467
113. Ramljak, S., Asif, A. R., Armstrong, V. W., Wrede, A., Groschup, M. H., Buschmann, A., et al. (2008). Physiological role of the cellular prion protein (PrPc): protein profiling study in two cell culture systems. J. Proteome Res. 7, 2681-2695. doi:10.1021/pr7007187
114. Rezaie, P., Pontikis, C. C., Hudson, L., Caims, N. J., and Lantos, P. L. (2005). Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study. J. Histochem. Cytochem. 53, 929-940. doi:10.1369/jhc.4A6551.2005
115. Rivest, S. (2009). Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 9, 429-439. doi:10.1038/nri2565
116. Rubio-Perez, J. M., and Morillas-Ruiz, J. M. (2012). A review: inflammatory process in Alzheimer's disease, role of cytokines. Scientific World Journal 2012:756357. doi:10.1100/2012/756357
117. Saijo, E., Scheff, S. W., and Telling, G. C. (2011). Unaltered prion protein expression in Alzheimer disease patients. Prion. 5, 109-116. doi:10.4161/pri.5.2.16355
118. Savaskan, N. E., Fingerle-Rowson, G., Buchfelder, M., and Eyüpoglu, I. Y. (2012). Brain miffed by macrophage inhibitory factor. Int. J. Cell Biol. 2012:139573. doi:10.1155/2012/139573
119. Scalabrino, G., and Veber, D. (2012). Normal prions as a new target of cobalamin (vitamin B12) in rat central nervous system. Clin. Chem. Lab. Med. 51, 601-606. doi:10.1515/cclm-2012-0474
120. Schmidt, C., Artjomova, S., Hoeschel, M., and Zerr, I. (2013). CSF prion protein concentration and cognition in patients with Alzheimer disease. Prion. 7, 229-234. doi:10.4161/pri.23904
121. Schwarze-Eicker, K., Keyvani, K., Görtz, N., Westaway, D., Sachser, N., and Paulus, W. (2005). Prion protein (PrPc) promotes beta-amyloid plaque formation. Neurobiol. Aging. 26, 1177-1182. doi:10.1016/j.neurobiolaging.2004.10.004
122. Shameli, A., Yamanouchi, J., Tsai, S., Yang, Y., Clemente-Casares, X., Moore, A., et al. (2013). IL-2 promotes the function of memory-like autoregulatory CD8+T cells but suppresses their development via FoxP3+ Treg cells. Eur. J. Immunol. 43, 394-403. doi:10.1002/eji.201242845
123. Smolen, J. S., Schoels, M. M., Nishmoto, N., Breedveld, F. C., Burmester, G. R., Dougados, M., et al. (2013). Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. Ann. Rheum. Dis. 72, 482-492. doi:10.1136/annrheumdis-2012-202469
124. Spittau, B., Zhou, X., Ming, M., and Krieglstein, K. (2012). IL6 protects MN9D cells and midbrain dopaminergic neurons from MPP+-induced neurodegeneration. Neuromolecular Med. 14, 317-327. doi:10.1007/s12017-012-8189-7
125. Stellato, F., Spevacek, A., Proux, O., Minicozzi, V., Millhauser, G., and Morante, S. (2011). Zinc modulates copper coordination mode in prion protein octa-repeats subdomains. Eur. Biophys. J. 40, 1259-1270. doi:10.1007/s00249-011-0713-4
126. Tokami, H., Ago, T., Sugimori, H., Kuroda, J., Awano, H., Suzuki, K., et al. (2013). RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke. Brain Res. 1517, 122-132. doi:10.1016/j.brainres.2013.04.022
127. Tsai, D. H., Amvai, N., Marques-Vidal, P., Wang, J. L., Riediker, M., Mooser, V., et al. (2012). Effects of particulate matter on inflammatory markers in the general adult population. Part. Fibre Toxicol. 9, 24. doi:10.1186/1743-8977-9-24
128. Tsutsui, S., Hahn, J. N., Johnson, T. A., Ali, Z., and Jirik, F. R. (2008). Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis. Am. J. Pathol. 173, 1029-1041. doi:10.2353/ajpath.2008.071062
129. Turtzo, L. C., Li, J., Persky, R., Benashski, S., Weston, G., Bucala, R., et al. (2013). Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice. Neurobiol. Dis. 54, 421-431. doi:10.1016/j.nbd.2013.01.016
130. Um, J. W., Nygaard, H. B., Heiss, J. K., Kostylev, M. A., Stagi, M., Vortmeyer, A., et al. (2012). Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat. Neurosci. 15, 1227-1235. doi:10.1038/nn.3178
131. Uski, O. J., Happo, M. S., Jalava, P. I., Brunner, T., Kelz, J., Obemberger, I., et al. (2012). Acute systemic and lung inflammation in C57BI/6J mice after intratracheal aspiration of particulate matter from small-scale biomass combustion appliances based on old and modern technologies. Inhal. Toxicol. 24, 952-965. doi:10.3109/08958378.2012.742172
132. Velayos, J. L., Irujo, A., Cuadrado-Tejedor, M., Paternain, B., Moleres, F. J., and Ferrer, V. (2009). The cellular prion protein and its role in Alzheimer disease. Prion. 3, 110-117. doi:10.4161/pri.3.2.9135
133. Viles, J. H., Cohen, F. E., Prusiner, S. B., Goodin, D. B., Wright, P. E., and Dyson, H. J. (1999). Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl. Acad. Sci. U.S.A. 96, 2042-2047. doi:10.1073/pnas.96.5.2042
134. Voigtländer, T., Klöppel, S., Birner, P., Jarius, C., Flicker, H., Verghese-Nikolakaki, S., et al. (2001). Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases. Acta Neuropathol. 101, 417-423.
135. Wang, J., Wicker, L. S., and Santamaria, P. (2009). IL-2 and its high-affinity receptor: genetic control of immunoregulation and autoimmunity. Semin. Immunol. 21, 363-371. doi:10.1016/j.smim.2009.04.004
136. Watt, N. T., Griffiths, H. H., and Hooper, N. M. (2013). Neuronal zinc regulation and the prion protein. Prion. 7, 203-208. doi:10.4161/pri.24503
137. C): its physiological function and role in disease. Biochim. Biophys. Acta. 1772, 629-644. doi:10.1016/j.bbadis.2007.02.011
138. Whitehouse, I. J., Jackson, C., Turner, A. J., and Hooper, N. M. (2010). Prion protein is reduced in aging and in speoradic but not in familial Alzheimer's disease. J. Alzheimers Dis. 22, 1023-1031.
139. Whitehouse, I. J., Miners, J. S., Glennon, E. B., Kehoe, P. G., Love, S., Kellet, K. A., et al. (2013). Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage. PLoS ONE 8:e59554 doi:10.1371/journal.pone.0059554
140. Willette, A. A., Bendlin, B. B., McLaren, D. G., Canu, E., Kastman, E. K., Kosmatka, K. J., et al. (2010). Age-related changes in neural volume and microstructure associated with interleukin-6 are ameliorated by a calorie-restricted diet in old rhesus monkeys. Neuroimage. 51, 987-994. doi:10.1016/j.neuroimage.2010.03.015
141. Wittkopp, S., Staimer, N., Tjoa, T., Gillen, D., Daher, N., Shafer, M., et al. (2013). Mitochondrial genetic background modifies the relationship between traffic-related air pollution exposure and systemic biomarkers of inflammation. PLoS ONE 8:e64444. doi:10.1371/journal.pone.0064444
142. Yan, J., Liu, J., Lin, C. Y., Anzgene, A. N., Csurhes, P. A., Pender, M. P., et al. (2012). Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis. Int. J. Mol. Sci. 13, 13667-13679. doi:10.3390/ijms131013667
143. Younan, N. D., Sarell, C. J., Davies, P., Brown, D. R., and Viles, J. H. (2013). The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers. FASEB J. 27, 1847-1858. doi:10.1096/fj.12-222588